Abstract
The effect of mitomycin C on two human ovarian cancer cell lines was measured during several exposure times and concentrations using the Human Tumour Colony-forming Assay (HTCA). Changes in exposure time and concentration resulted in considerable differences in tumour cell survival. It is concluded that several exposure times and concentrations are necessary for in vitro sensitivity testing. We suggest alternative criteria derived from pharmacokinetic data in patients instead of one-tenth of the peak plasma level which is the usual practice.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Slee, P., de Bruijn, E., Leeflang, P. et al. Variations in exposure to mitomycin C in an in vitro colony-forming assay. Br J Cancer 54, 951–955 (1986). https://doi.org/10.1038/bjc.1986.266
Issue Date:
DOI: https://doi.org/10.1038/bjc.1986.266
This article is cited by
-
Pharmacokinetics of UGN-101, a mitomycin-containing reverse thermal gel instilled via retrograde catheter for the treatment of low-grade upper tract urothelial carcinoma
Cancer Chemotherapy and Pharmacology (2021)
-
High mitomycin C concentration in tumour tissue can be achieved by isolated liver perfusion in rats
Cancer Chemotherapy and Pharmacology (1991)
